AGT and type 2 diabetes mellitus: In summary, our results, for the first time, demonstrate that AngII promotes the anticoagulant effects of rivaroxaban via AT2R and Mas signaling in an experimental mouse model with type 2 diabetes mellitus, and TFPI is likely a key mediator.